- Regents’ Professor of Chemistry
- Georgia Research Alliance Eminent Scholar
- Georgia Cancer Coalition Distinguished Cancer Scholar
- Director, Center for Diagnostics and Therapeutics
Getting to Know B.Wang
Medicinal Chemistry (Drug design), pharmaceutical chemistry (drug delivery), chemical biology, supramolecular chemistry and chemosensing, and bioorganic chemistry
General Research Interest
Organic, Bioorganic, and Medicinal Chemistry
- Editor-in-Chief, Medicinal Research Reviews (ranked #2 in 2016 based on Impact Factors (8.4) among about 60 medicinal chemistry journals worldwide and #6 among 261 pharmacology- and pharmacy-related journals)
- Founding Serial Editor, A Wiley Series in Drug Discovery and Development
- Distinguished Alumni Professor Award, Georgia State University, 2007
- Outstanding Faculty Scholarship Award, Georgia State University, 2007
- Memberships on more than 30 NIH Study Sections during the past 10 years
- Permanent membership on the Synthetic and Biological Study-A Section (SBC-A) (2011-2017)
- Member, Long Range Planning Committee, Division of Medicinal Chemistry, American Chemical Society, 2001-2004
- American Heart Association Established Investigator Awardee, 1998
- Oklahoma Society of Hospital Pharmacists Outstanding Faculty Award, 1996 (for teaching)
- Kappa Psi Outstanding Faculty Award, College of Pharmacy, University of Oklahoma Health Sciences Center, 1996 (for teaching)
- Kappa Epsilon Outstanding Faculty Award, College of Pharmacy, University of Oklahoma Health Sciences Center, 1996 (for teaching)
- NIH FIRST Awardee, 1995
"A click-and-release approach to CO prodrugs." Chemical Communications 50, no. 100 2014: 15890-15893
“Click and Release: A Chemical Strategy toward Developing Gasotransmitter Prodrugs by Using an Intramolecular Diels-Alder Reaction” Angew. Chem. Int. Ed. Engl. 2016, 55, 15846-15851.
“Enrichment-triggered Prodrug Activation Demonstrated through Mitochondria-targeted Delivery of Doxorubicin and Carbon Monoxide” Nature Chem. 2018, 10, 787-794.
“pH-sensitive Metal-free Carbon Monoxide Prodrugs with Tunable and Predictable Release Rates” Chem. Commun. 2017, 53, 9628 - 9631.
“Organic CO prodrugs activated by endogenous ROS” Org. Lett. 2018, 20, 8-11.
“An Esterase-activated Click and Release Approach to Metal-free CO-prodrugs” Chem. Commun. 2017, 53, 8296-8299